Bo Shen/iStock Editorial via Getty Images
- Greek pharma company Genesis Pharma on Wednesday announced a revision to its 2019 commercial agreement with Alnylam Pharmaceuticals (ALNY) to market the U.S. biotech’s RNAi therapeutics in four additional countries across Europe.
- The long-running collaboration, which initially covered Alnylam’s (